Cannabis Offers Sustained Relief for Neuropathic Pain: A German Study Unveils

2023-10-06T15:57:30Z
Prescription pills with medical cannabis

Introduction

Neuropathic pain is a debilitating condition affecting millions worldwide. Traditional treatments often fall short in providing long-term relief. However, a recent German study offers promising results, indicating that cannabis could be a game-changer in treating neuropathic pain.

Understanding Neuropathic Pain

Neuropathic pain arises from nerve damage, often due to injury or infection. It is characterised by a burning sensation, tingling, or numbness. According to international researchers, nearly 7% of the global population suffers from some form of neuropathic pain.

The German Study: An Overview

The study, published in the journal Medical Cannabis and Cannabinoids, involved 99 patients suffering from neuropathic pain. Participants inhaled cannabis with moderate THC levels (12 to 22 percent) for six weeks. The study reported significant improvements in pain and sleep quality.

Key Findings

Researchers observed that within six weeks of cannabis therapy:

  • Median pain scores decreased from 7.5 to 4.0
  • Patients with severe pain reduced from 96% to 16%
  • Sleep disturbance scores improved from 8.0 to 2.0

Implications for Pain Management

The study's findings could revolutionise the way neuropathic pain is managed. It suggests that cannabis can be an effective, sustainable, and safe treatment option. This is particularly significant given the current reliance on pharmaceutical medications, including anti-seizure drugs, which often come with side effects.

Comparative Studies

Other surveys have reported similar findings, strengthening the case for cannabis as a viable treatment option. Data published in the Journal of the American Medical Association (JAMA) Network Open also indicated that many patients are substituting cannabis for opioids.

What's Next?

While the results are promising, further research is needed to understand the long-term effects and potential risks. However, the study adds to the growing body of evidence supporting the medical use of cannabis, particularly for chronic pain conditions.

Conclusion

The German study on the effectiveness of cannabis in treating neuropathic pain is a significant milestone in medical research. It not only offers hope to millions suffering from this debilitating condition but also opens new avenues for the use of cannabis in healthcare.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.

Robin Roy Krigslund-Hansen

Robin Roy Krigslund-Hansen

About the author:

Robin Roy Krigslund-Hansen is known for his extensive knowledge and expertise in the fields of CBD and hemp production. With a career spanning over a decade in the cannabis industry, he has dedicated his life to understanding the intricacies of these plants and their potential benefits to human health and the environment. Over the years, Robin has worked tirelessly to promote the full legalization of hemp in Europe. His fascination with the plant's versatility and potential for sustainable production led him to pursue a career in the field.

More about Robin Roy Krigslund-Hansen

Related Products